KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $50.9 million.

  • Fulgent Genetics' Operating Expenses rose 1599.09% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.1 million, marking a year-over-year decrease of 3501.27%. This contributed to the annual value of $181.1 million for FY2024, which is 3961.93% down from last year.
  • Latest data reveals that Fulgent Genetics reported Operating Expenses of $50.9 million as of Q3 2025, which was up 1599.09% from $54.1 million recorded in Q2 2025.
  • Fulgent Genetics' Operating Expenses' 5-year high stood at $176.4 million during Q4 2023, with a 5-year trough of $18.4 million in Q1 2021.
  • Over the past 5 years, Fulgent Genetics' median Operating Expenses value was $43.9 million (recorded in 2024), while the average stood at $48.6 million.
  • Per our database at Business Quant, Fulgent Genetics' Operating Expenses surged by 25598.22% in 2023 and then crashed by 7279.05% in 2024.
  • Fulgent Genetics' Operating Expenses (Quarter) stood at $38.7 million in 2021, then increased by 28.08% to $49.5 million in 2022, then soared by 255.98% to $176.4 million in 2023, then tumbled by 72.79% to $48.0 million in 2024, then increased by 6.0% to $50.9 million in 2025.
  • Its last three reported values are $50.9 million in Q3 2025, $54.1 million for Q2 2025, and $48.1 million during Q1 2025.